LncRNA FGF13-AS1 suppressed cell glycolysis and stemness properties via insulin-like growth factor 2 mRNA binding proteins (IGF2BPs)/c-Myc pathway in breast cancer [24]. This evidence concerns the gene FGF13 and breast carcinoma.